Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (371-380 of 567) with videos related to

Pageof 57
Sort By:
American Heart Journal|August 1, 1989
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortalityE R Bates, R M Califf, R S Stack, et al.
Circulation|June 3, 1998
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG InvestigatorsN S Kleiman, A M Lincoff, D J Kereiakes, et al.
The American Journal of Cardiology|December 15, 1990
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study GroupT C Wall, R M Califf, L Harrelson-Woodlief, et al.
Circulation|April 1, 1994
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trialE J Topol, V Fuster, R A Harrington, et al.
European Journal of Heart Failure|August 11, 2000
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomesC M O'Connor, W A Gattis, F Zannad, et al.
Journal of the American College of Cardiology|September 15, 2000
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevationD Hasdai, R A Harrington, J S Hochman, et al.
Circulation|April 1, 1995
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I InvestigatorsR J Simes, E J Topol, D R Holmes, et al.
Journal of the American College of Cardiology|October 13, 1998
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventionsR D Anderson, E M Ohman, D R Holmes, et al.
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
Pageof 57

Showing results (371-380 of 567) with videos related to

Sort By:
Pageof 57
American Heart Journal|August 1, 1989
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study GroupD J Kereiakes, E J Topol, B S George, et al.
Journal of the American College of Cardiology|January 1, 1989
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortalityE R Bates, R M Califf, R S Stack, et al.
Circulation|June 3, 1998
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG InvestigatorsN S Kleiman, A M Lincoff, D J Kereiakes, et al.
The American Journal of Cardiology|December 15, 1990
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study GroupT C Wall, R M Califf, L Harrelson-Woodlief, et al.
Circulation|April 1, 1994
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trialE J Topol, V Fuster, R A Harrington, et al.
European Journal of Heart Failure|August 11, 2000
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomesC M O'Connor, W A Gattis, F Zannad, et al.
Journal of the American College of Cardiology|September 15, 2000
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevationD Hasdai, R A Harrington, J S Hochman, et al.
Circulation|April 1, 1995
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I InvestigatorsR J Simes, E J Topol, D R Holmes, et al.
Journal of the American College of Cardiology|October 13, 1998
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventionsR D Anderson, E M Ohman, D R Holmes, et al.
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
Pageof 57